Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 30.00 | |
2 mg | In stock | $ 40.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 113.00 | |
25 mg | In stock | $ 239.00 | |
50 mg | In stock | $ 397.00 | |
100 mg | In stock | $ 655.00 | |
200 mg | In stock | $ 918.00 | |
500 mg | In stock | $ 1,360.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease. |
Molecular Weight | 329.48 |
Formula | C20H31N3O |
CAS No. | 1629138-41-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (166.93 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SRI-011381 1629138-41-5 Stem Cells TGF-beta/Smad Transforming growth factor beta inhibit multiple neuroprotective NALP3 collagen-1 SRI011381 TGF-β sclerosis Inhibitor SRI 011381 α-SMA inhibitor